SAN DIEGO, CA - Hempacco Co., Inc., a company specialized in the manufacturing of cigarettes, received a notice from the Nasdaq Stock Market LLC on September 4, 2024, indicating the company's securities would no longer be listed on the exchange.
The decision comes after Hempacco failed to meet Nasdaq's requirements for holding an annual shareholders' meeting and filing periodic financial reports, as stipulated in Nasdaq Listing Rules 5620(a) and 5250(c)(1).
The company, which is incorporated in Nevada and has its principal executive offices in San Diego, California, now has the opportunity to appeal Nasdaq's decision. Hempacco intends to request a review by the Nasdaq Listing and Hearing Review Council and has scheduled an annual meeting of shareholders in an effort to address the compliance issues.
Additionally, the company is working on filing the overdue periodic reports. Despite these efforts, Hempacco has acknowledged that there is no guarantee that they will meet the 15-day deadline to request the review or that the review will result in a reversal of the delisting decision.
Following the notice, Hempacco's common stock, traded under the symbol HPCO, began trading on the Expert Market of the OTC Link alternative trading system operated by OTC Markets Group Inc. as of September 6, 2024.
If the company's appeal to Nasdaq is unsuccessful, or if they choose not to appeal, Hempacco plans to apply for its common stock to be quoted on the OTCQB Venture Market. However, there is no certainty that the stock will be approved for quotation or will continue to be quoted on this market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.